Citation only
via Europe PMC
Chronic Chagas disease and type 2 diabetes comorbidity. The scenario in which two differently driven inflammatory mechanisms meet.
Dinatale B, González FB, Bottasso OA, Pérez AR.
Seminars in immunology · 2026
Abstract
Chagas disease (ChD) and Type 2 diabetes (T2D) originate from distinct etiological processes -infectious and metabolic, respectively- yet both share a chronic inflammatory and metabolic imbalance that profoundly impacts immune-endocrine homeostasis. Persistent Trypanosoma cruzi infection in ChD induces sustained immune activation, altered adrenal steroid balance, and tissue remodeling, whereas T2D is characterized by metabolic inflammation, oxidative stress, and insulin resistance. When these two conditions coexist, their overlapping inflammatory, metabolic, and endocrine circuits may act synergistically, amplifying metabolic toxicity, immune exhaustion, and premature immunosenescence. In addition, this comorbidity thus represents the convergence of pathogen-driven and metabolism-driven inflammation, resulting in a disrupted neuroendocrine-immune dialogue and heightened susceptibility to tissue damage, particularly in the heart. Understanding the mechanistic basis of this interplay is crucial, as it highlights shared pathogenic pathways and potential molecular targets for integrated therapeutic interventions. Altogether, recognizing ChD+T2D coexistence as a mechanistic rather than merely epidemiological association provides new insights into the links between chronic infection, metabolic dysfunction, and immune aging-offering a conceptual framework for future studies aimed at restoring immune-metabolic balance and improving disease outcomes, particularly cardiac damage.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1016/j.smim.2026.102028
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
B, D., FB, G., OA, B., & AR., P. (2026). Chronic Chagas disease and type 2 diabetes comorbidity. The scenario in which two differently driven inflammatory mechanisms meet. <em>Seminars in immunology</em>. https://doi.org/10.1016/j.smim.2026.102028
Vancouver
B D, FB G, OA B, AR. P. Chronic Chagas disease and type 2 diabetes comorbidity. The scenario in which two differently driven inflammatory mechanisms meet. Seminars in immunology. 2026. doi:10.1016/j.smim.2026.102028.
BibTeX
@article{dinatale2026Chroni,
title = {Chronic Chagas disease and type 2 diabetes comorbidity. The scenario in which two differently driven inflammatory mechanisms meet.},
author = {Dinatale B and González FB and Bottasso OA and Pérez AR.},
journal = {Seminars in immunology},
year = {2026},
doi = {10.1016/j.smim.2026.102028},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Pharmacology 2021
Open access · CC-BY
Senescence and Type 2 Diabetic Cardiomyopathy: How Young Can You Die of Old Age?
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018
Open access · OA
Type 2 diabetes – An autoinflammatory disease driven by metabolic stress
PubMed 2016
Preprint
Inflammaging.
Experimental Gerontology 2026
Open access · CC-BY
Immunosenescence, inflammaging, and metabolic disease: A geroscience perspective on mechanisms and links
Innovative Medicines & Omics 2026
Open access · CC-BY
Inflammaging as a systems-level integrator of disease: Biological foundations of chronic low-grade inflammation
Inflammatory Bowel Diseases 2015
Citation only